July 2-3, 2026 | Basel
DMDG Biotransformation Workshop 2026
The DMDG Biotransformation Workshop provides a focused forum for scientists working on drug metabolism, with a program oriented around technical exchange between sponsors, CROs, and academic groups.
Peregrion attends to discuss the application of AMS microtracer to human biotransformation studies, including metabolite characterisation at sub-radioactive doses.
Activities
Participation in workshop sessions and discussions.
1:1 meetings with scientific staff around the program.
Attending from Peregrion
- Steven Erpelinck (Chief Commercial Officer)
- Suzanne van Gerwen (VP Business Development)
- Alana Pereira (Scientist)
- Jelle Reijnen (Scientist)
Topics for discussion
- Human metabolite profiling and identification at microtracer doses
- AMS-enabled biotransformation work for compounds unsuitable for conventional radiolabel approaches
- Combined LC-AMS and high-resolution MS workflows for metabolite characterisation
- Design considerations for biotransformation in first-in-human studies
- Case-specific scientific discussions
Book a meeting with our team: info@peregrion.com.
